These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 2833302)

  • 21. Phase I trial of dipyridamole with 5-fluorouracil and folinic acid.
    Budd GT; Jayaraj A; Grabowski D; Adelstein D; Bauer L; Boyett J; Bukowski R; Murthy S; Weick J
    Cancer Res; 1990 Nov; 50(22):7206-11. PubMed ID: 2224854
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A pilot study on intensive weekly 24-hour intra-arterial infusion with 5-fluorouracil and folinic acid for colorectal liver metastases.
    Lorenz M; Staib-Sebler E; Gog C; Petrowsky H; Köhne CH; Encke A
    Oncology; 1998; 55(1):53-8. PubMed ID: 9428376
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Twenty-four hour intra-arterial infusion of 5-fluorouracil, cisplatin, and leucovorin is more effective than 6-hour infusion for advanced hepatocellular carcinoma.
    Nagai H; Kanayama M; Higami K; Momiyama K; Ikoma A; Okano N; Matsumaru K; Watanabe M; Ishii K; Sumino Y; Miki K
    World J Gastroenterol; 2007 Jan; 13(2):280-4. PubMed ID: 17226909
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Is liver disease an octreotide side effect?
    Uygur-Bayramiçli O; Gemici C
    J Clin Gastroenterol; 2003 Jul; 37(1):86-7. PubMed ID: 12811219
    [No Abstract]   [Full Text] [Related]  

  • 25. High-dose continuous infusion folinic acid and bolus 5-fluorouracil in patients with advanced colorectal cancer: a phase II study.
    Bertrand M; Doroshow JH; Multhauf P; Blayney DW; Carr BI; Cecchi G; Goldberg D; Leong L; Margolin K; Metter G
    J Clin Oncol; 1986 Jul; 4(7):1058-61. PubMed ID: 3487626
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Treatment of hepatic malignant tumors with percutaneous echoguided injections of absolute alcohol and 5 FU- folinic acid-ultrafluid lipiodol combination. Preliminary results in 17 patients].
    Giovannini M; Seitz JF
    Gastroenterol Clin Biol; 1992; 16(5):488-9. PubMed ID: 1326459
    [No Abstract]   [Full Text] [Related]  

  • 27. Hepatic Arterial Infusion of Oxaliplatin, Fluorouracil, and Leucovorin in Hepatocellular Cancer with Extrahepatic Spread.
    Lyu N; Kong Y; Pan T; Mu L; Li S; Liu Y; Deng H; Li J; Shi M; Xu L; Guo R; Chen M; Wu P; Zhao M
    J Vasc Interv Radiol; 2019 Mar; 30(3):349-357.e2. PubMed ID: 30819477
    [TBL] [Abstract][Full Text] [Related]  

  • 28. 5-Fluorouracil combined with the [6S]-stereoisomer of folinic acid in high doses for treatment of patients with advanced colorectal carcinoma. A phase I-II study of two consecutive regimens.
    Machover D; Grison X; Goldschmidt E; Zittoun J; Metzger G; Richaud J; Lotz JP; André T; Hannoun L; Marquet J
    Ann Oncol; 1993; 4 Suppl 2():29-35. PubMed ID: 8353102
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Is continuous 24-hour infusion of 5-fluorouracil plus high-dose folinic acid effective in patients with progressive or recurrent colorectal cancer? A phase II study.
    Hartmann JT; Köhne CH; Schmoll HJ; Daikeler T; Kanz L; Bokemeyer C
    Oncology; 1998; 55(4):320-5. PubMed ID: 9663421
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Hepatic arterial chemotherapy with oxaliplatin, folinic acid and 5-fluorouracil in pre-treated patients with liver metastases from colorectal cancer.
    Del Freo A; Fiorentini G; Sanguinetti F; Muttini MP; Pennucci C; Mambrini A; Pacetti P; Della Seta R; Lombardi M; Torri T; Cantore M
    In Vivo; 2006; 20(6A):743-6. PubMed ID: 17203759
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Basic research supported developments of chemotherapy in nonresectable isolated colorectal liver metastases to a protocol of hepatic artery infusion using mitoxantrone, 5-FU + folinic acid and mitomycin C.
    Link KH; Kornmann M; Leder G; Pillasch AF; Sunelaitis E; Schatz M; Pressmar J; Beger HG
    Gan To Kagaku Ryoho; 1999 Feb; 26(3):269-81. PubMed ID: 10065089
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Paclitaxel combined with weekly high-dose 5-fluorouracil/folinic acid and cisplatin in the treatment of advanced breast cancer.
    Klaassen U; Wilke H; Seeber S
    Semin Oncol; 1996 Oct; 23(5 Suppl 11):32-7. PubMed ID: 8893897
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Multicenter phase II study of the Liver Metastases Study Group of weekly intra-arterial 24-hour high dose therapy with 5-FU and folinic acid (FA) in liver metastases of colorectal tumors].
    Staib-Sebler E; Müller HH; Mattes P; Junginger T; Saeger HD; Lorenz M
    Langenbecks Arch Chir Suppl Kongressbd; 1998; 115():1441-4. PubMed ID: 9931906
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Up-date of the chemotherapy of carcinoma of the colo-rectum: our experience with 5-fluorouracil and folinic acid in high doses].
    Manguso L; Coraggio F; Grimaldi G; Zito GA; Grimaldi F; Vespoli F; Gentile B
    Clin Ter; 1984 Aug; 110(4):327-39. PubMed ID: 6237868
    [No Abstract]   [Full Text] [Related]  

  • 35. [Combination of 5-fluorouracil and high doses of folinic acid in the treatment of recurrent and persistent spinocellular carcinoma of the head and neck. A phase II study].
    Bacigalupo A; Benasso M; Cavallari M; Merlano M; Sampietro M; Scasso F; Pallestrini E; Barbieri A; Cantoni E; Grimaldi A
    Acta Otorhinolaryngol Ital; 1988; 8(6):575-80. PubMed ID: 3266818
    [No Abstract]   [Full Text] [Related]  

  • 36. A Phase I Study of Combination Therapy with Sorafenib and 5-Fluorouracil in Patients with Advanced Hepatocellular Carcinoma.
    Sho T; Nakanishi M; Morikawa K; Ohara M; Kawagishi N; Izumi T; Umemura M; Ito J; Nakai M; Suda G; Ogawa K; Chuma M; Meguro T; Nakamura M; Nagasaka A; Horimoto H; Yamamoto Y; Sakamoto N
    Drugs R D; 2017 Sep; 17(3):381-388. PubMed ID: 28573606
    [TBL] [Abstract][Full Text] [Related]  

  • 37. 5-Fluorouracil plus high dose levofolinic acid and oral hydroxyurea for the treatment of primary hepatocellular carcinomas: results of a phase II multicenter study of the Southern Italy Oncology Group (G.O.I.M.).
    Gebbia V; Maiello E; Serravezza G; Giotta F; Testa A; Borsellino N; Pezzella G; Colucci G
    Anticancer Res; 1999; 19(2B):1407-10. PubMed ID: 10365114
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Combination chemotherapy and radiation for palliation of hepatocellular carcinoma.
    Dhir V; Swaroop VS; Mohandas KM; Dinshaw KA; Desai DC; Nagral A; Sharma V; Jagannath P; Desouza LJ
    Am J Clin Oncol; 1992 Aug; 15(4):304-7. PubMed ID: 1381143
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Randomized, multicenter, open-label study of oxaliplatin plus fluorouracil/leucovorin versus doxorubicin as palliative chemotherapy in patients with advanced hepatocellular carcinoma from Asia.
    Qin S; Bai Y; Lim HY; Thongprasert S; Chao Y; Fan J; Yang TS; Bhudhisawasdi V; Kang WK; Zhou Y; Lee JH; Sun Y
    J Clin Oncol; 2013 Oct; 31(28):3501-8. PubMed ID: 23980077
    [TBL] [Abstract][Full Text] [Related]  

  • 40. 5-Fluorouracil and d,l-leucovorin calcium are active to treat unresectable hepatocellular carcinoma patients: preliminary results of a phase II study.
    Porta C; Moroni M; Nastasi G; Arcangeli G
    Oncology; 1995; 52(6):487-91. PubMed ID: 7478436
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.